Industry Influence

Industry Influence: News Blog Analysis All Articles

Subtopics

News

Bush Continues Anti-Regulatory Efforts with Industry Nominee to CPSC 03/06/2007
In nominating Michael E. Baroody Mar. 1 to be chairman of the Consumer Product Safety Commission (CPSC), President Bush demonstrated yet another example since the 2006 elections of his efforts to slow down or roll back government regulation. CPSC is the independent regulatory agency charged with protecting the public against injury and death from a wide range of consumer products. Read More

FDA Drug Approval Process under Scrutiny 02/21/2007
The U.S. Food and Drug Administration (FDA) is facing renewed criticism over the process by which it approves drugs for market. Recent reports indicate many drugs are approved before they are proven safe, and problems with the agency's structure and processes prevent it from fulfilling its mission. Subsequently, Congress has started using its oversight powers to scrutinize the agency, and the clamor for FDA reform is growing louder. Read More

Bush Nominates Anti-Regulatory Zealot to Head Regulatory Policy 08/08/2006
The White House has nominated Susan Dudley, an anti-regulatory extremist from the industry-funded Mercatus Center, to an obscure but powerful office where she would have the power to gut the federal government's very ability to protect the public. Read More

Cow Sense: The Bush Administration's Broken Record on Mad Cow Disease 04/06/2006

The Bush administration has failed the public time and time again on mad cow disease, putting corporate special interests above the public interest.

Read More

Foxes in the Henhouse: OSHA, MSHA Nominees Appear Pro-Industry, Anti-Worker 02/07/2006
Employing an all-too-familiar strategy, the White House has put forward two industry-insiders as its nominees for the top posts at the Occupational Safety and Health Administration (OSHA) and the Mine Safety and Health Administration (MSHA). Read More

Regulatory Year in Review: 2005 12/13/2005
A round-up of the key developments in regulatory policy we have covered in 2005. Read More

Industry Costs Pitted Against Public Needs in Homeland Security Policy 11/15/2005
How much is a human life worth when it comes to a terrorist attack? Should the public be involved in setting the nation's safety priorities? The Bush administration is offering surprising answers to these questions and more as it develops the general framework for homeland security policy. Read More

Nanotech, Genetically Modified Crop News Spotlights Regulatory Gaps 11/01/2005
New evidence of long-term persistence of genetically modified crops and new concerns about gaps in monitoring of nanotechnology underscore the risks from failing to embed the Precautionary Principle in regulatory policy. Read More

High Court Nominee Admits Lobbying OMB, FDA 08/08/2005
Supreme Court nominee John G. Roberts, Jr. conceded that he omitted records of lobbying the White House Office of Management and Budget (OMB) and U.S. Food and Drug Administration (FDA) from his other public disclosures, after Newsday uncovered the lobbying activities. Read More

Administration Withholds Rationales Behind Anti-Regulatory Hit List 07/25/2005
The Bush administration is refusing to inform the public about the justifications for deciding which regulatory protections were added to its hit list of safeguards to be weakened or eliminated. Read More

| < 1 >

| 2

| 3

| 4

| Next >>